The virtual assay software for human in silico drug trials to augment drug cardiac testing

類似資料

• Drug‐induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias
  著者:: Passini, E, 等
  出版事項: (2019)
• Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment
  著者:: Zhou, X, 等
  出版事項: (2020)
• Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction
  著者:: Cristian Trovato, 等
  出版事項: (2022-10-01)
• Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity
  著者:: Passini, E, 等
  出版事項: (2017)
• P511 In silico trials in human ventricular and purkinje cell models predict safety and efficacy of 10 antiarrhythmic drugs
  著者:: Trovato, C, 等
  出版事項: (2017)